# FDA Inspection 999660 - In2Bones USA, LLC - January 19, 2017

Source: https://www.keypedia.com/records/fda_inspections/in2bones-usa-llc/5f51128f-bd32-4e2f-b01f-30876d5d0791
Source feed: FDA_Inspections

> FDA Inspection 999660 for In2Bones USA, LLC on January 19, 2017. Classification: No Action Indicated (NAI).

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 999660
- Company Name: In2Bones USA, LLC
- Inspection Date: 2017-01-19
- Classification: No Action Indicated (NAI)
- Project Area: Human Cellular, Tissue, and Gene Therapies
- Product Type: Biologics
- Office Name: Center for Biologics Evaluation and Research

## Related Documents

- [FDA Inspection 1233559 - 2024-03-13](https://www.keypedia.com/records/fda_inspections/in2bones-usa-llc/c3c817c6-1aab-4e35-ac3f-bc7e50aed038)
- [FDA Inspection 1122918 - 2020-02-13](https://www.keypedia.com/records/fda_inspections/in2bones-usa-llc/fee30f8a-25de-4941-b5cf-8d0c07586b39)

Company: https://www.keypedia.com/companies/in2bones-usa-llc/6e97b52f-a3d6-4787-9694-ad8f097c74bf

Office: https://www.keypedia.com/offices/center-for-biologics-evaluation-and-research/dd9e8ea7-6f04-4ed1-b0d7-e7e6b264570d